Welcome and Overview of Myeloma
Case-Based Discussions of Current Data
- Diagnosis and Risk Stratification of Plasma Cell Disorders: To Treat or Not to Treat?
- Individualized Approaches to Frontline Treatment Selection
- Therapeutic Strategies for Patients With Relapsed/Refractory MM
Current Supportive Care Strategies for MM-Related and Treatment-Related Events
Promising New Treatment Options for Patients With MM
Final Thoughts and Audience Questions
Date / Time
Sarah Holstein, MD, PhD
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Jonathan Kaufman, MD
Winship Cancer Institute
Ajai Chari, MD
Associate Professor of Medicine
Mount Sinai School of Medicine
Director of Clinical Research
Multiple Myeloma Program
New York, New York
Carol Ann Huff, MD
Medical Director, Sidney Kimmel Comprehensive Cancer Center
Associate Professor of Medicine and Oncology
Multiple Myeloma Program
Johns Hopkins University
Shaji Kumar, MD
Department of Hematology
The goal of this activity is to improve the knowledge, competence, and performance of learners to integrate current and emerging therapies into the treatment of patients with multiple myeloma.
This program is intended for physicians, nurses, pharmacists, and other healthcare providers who care for patients with multiple myeloma.
Upon completion of this activity, participants should be able to:
- Integrate timely systemic treatment for appropriate patients based on the latest multiple myeloma diagnosis and staging criteria
- Plan individualized treatment strategies for patients with multiple myeloma through consideration of the available clinical data as well as risk assessment, comorbidities, and patient age/fitness and preferences
- Describe the efficacy and safety evidence of novel combination therapeutic regimens for patients with multiple myeloma
- Manage disease-related and treatment-related symptoms in patients with multiple myeloma
Learning objectives apply to all professions in the target audience.
USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Continuing Medical Education
USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
USF Health is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 1.0 contact hour may be earned by learners who successfully complete this continuing nursing education activity.
Pharmacist Continuing Education
USF Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program has been approved for 1.0 contact hour (0.1 CEU). Universal program number is as follows:
UAN# for live meetings: 0230-9999-20-009-L01-P
UAN# for webcasts: 0230-9999-20-010-L01-P
It is the responsibility of the pharmacy participant to ensure the provider has the learner’s birthday and e-Profile ID (ePID)/NABP number; it is the responsibility of the provider to submit to CPE Monitor participant information within 60 days of the activity for all participants who have attended, attested to their participation, and provided their ePID/NABP number and birthdate.
ACPE indicates it is the responsibility of the pharmacy professional to confirm the status of their NABP contact hours before 60 days past the activity. If there are any discrepancies, contact the provider immediately. You may contact USF Health through firstname.lastname@example.org.
Disclosure of Conflicts of Interest
USF Health adheres to ACCME, ANCC, and ACPE Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose relevant conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
The information provided at this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
If you have any questions relating to the continuing education accreditation of this activity, please contact USF Health at 813-224-7860 or email@example.com.